science
Renue By Science Launches Copper Peptide Cream With NAD+ Complex

Renue By Science has introduced a face cream that pairs the copper peptide GHK-Cu with what the company describes as an NAD+ complex, according to a report from Trend Hunter aggregated by Google News and reviewed by HTT News. The item did not include a published clinical trial, an ingredient-concentration breakdown, or pricing information in the material examined for this report.
What ingredients does the new cream combine?
The formula centers on two actives, per the report: GHK-Cu, a copper-binding tripeptide that has circulated in skincare marketing for years, and an NAD+ complex, a category of ingredient increasingly promoted in anti-aging product lines across the industry. The Trend Hunter item reviewed by HTT News described the pairing but did not list percentage concentrations for either ingredient, nor did it specify how the two actives are stabilized together in a single formula—a detail that affects how peptides and cofactors behave once applied to skin.
What is GHK-Cu and why do formulators use it?
GHK-Cu, short for glycyl-histidyl-lysine copper, is one of the most frequently referenced copper peptides in skincare formulation discussions, typically marketed around claims tied to skin's response to copper exposure. The report reviewed by HTT News did not cite a peer-reviewed study, a sample size, or a research institution backing the specific version of GHK-Cu used in the Renue By Science formula. Readers looking for general background on how active ingredients are typically evaluated in skincare research can review HTT News' earlier explainer on retinol versus retinal, which outlines how two related vitamin A derivatives are studied and compared.
What does the NAD+ complex reportedly add to the formula?
NAD+, or nicotinamide adenine dinucleotide, is a coenzyme that has become a recurring ingredient claim in cellular-energy-focused skincare marketing broadly, not limited to this product. The Trend Hunter report did not specify whether Renue By Science's complex is a direct NAD+ molecule, a precursor compound, or a proprietary blend, nor did it include independent laboratory testing results for the finished cream. HTT News could not identify a named researcher or dermatologist quoted in the available reporting regarding this specific formulation.
Has any outside lab or dermatologist verified the product's claims?
Based on the material reviewed for this report, no. The available coverage describes the ingredient pairing without an accompanying clinical trial, journal citation, or named research source specific to this cream. HTT News' prior reporting on science-backed skincare routine habits notes that ingredient claims in the broader market are often evaluated against patch testing and concentration transparency rather than marketing copy alone—standards not addressed in the Trend Hunter item.
How does this fit with other copper-peptide and NAD+ trends in skincare?
The pairing reflects two marketing trends converging in a single product: copper peptides, promoted for years under claims tied to skin firmness and texture, and NAD+ ingredients, which have expanded into topical lines alongside wider consumer interest in cellular-energy and longevity-adjacent wellness products. Neither trend, as covered in the source material reviewed here, is accompanied by a sample size, journal reference, or peer-reviewed outcome data tied specifically to the Renue By Science cream.
A brief timeline of the coverage
- Trend Hunter published a description of the Renue By Science formula combining GHK-Cu and an NAD+ complex.
- The item was indexed and aggregated through Google News.
- HTT News Science Desk reviewed the aggregated report on Nov. 18, 2026, and found no additional primary documentation—such as a clinical trial registration or company press release—attached to the coverage.
What should shoppers know before buying this cream?
Based on the available reporting, shoppers weighing the new cream have no independently published laboratory data, concentration figures, or named clinical sources to review at this time. HTT News will update this report if Renue By Science publishes clinical data or research specific to the GHK-Cu and NAD+ combination.